Following the publication of reports that the effectiveness of some types of Quid-19 vaccines against the African variant Corona virus (B.1.351) has been reduced, the
In this regard, blood samples of 10 and 30 volunteers of phases 1 and 2 of the clinical study were studied and the results showed that the antibodies in the blood of these people have the ability to neutralize the African variant (B.1.351).
It should be noted that previous experiments have shown the high efficacy of Kovayran Barakat vaccine against the English variant.
It should be noted that research on the efficacy of Barakat Kovairan vaccine against Indian variant (B.1.617) has been presented and the results will be announced to the honorable people of Iran.
